Document is current
Any future updates will be listed below
-
Authors
Immovilli, Paolo https://orcid.org/0000-0001-9417-3903
Schiavetti, Irene
Cordioli, Cinzia
De Mitri, Paola
Grazioli, Silvia
Guidetti, Donata
Sormani, Maria Pia
- License Information
-
More Information
Article History
Received: 30 June 2022
Accepted: 8 August 2022
First Online: 13 August 2022
Declarations
:
: The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Patients signed informed consent regarding publishing their data.
: Not applicable.
: P. Immovilli has received consulting fees from Roche, Biogen, Merck, Novartis and Sanofi. M.P. Sormani has received consulting fees from Biogen, Boehringer Ingelheim, GeNeuro, GSK, Immunic, Merck, Novartis, Roche, and Sanofi. C. Cordioli has received consulting fees from Biogen, Merck Serono, Novartis, Bristol Myers Squibb, Roche, Almirall. I. Schiavetti has received consulting fees from Associazione Commissione Difesa Vista, Eye Pharma, Hippocrates Research, and D.M.G Italia outside the submitted work. P. De Mitri, S. Grazioli, D Guidetti have nothing to disclose.
Free to read: This content has been made available to all.
